Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1713 to 1762 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1713\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SH3GL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 3 (sh3 domain protein 2c) (een-b2). [source:swissprot;acc:q99963]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.823\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
204.111\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01329\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1714\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ARMET\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
armet protein precursor (arginine-rich protein). [source:swissprot;acc:p55145]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
206.549\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
203.844\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01327\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1715\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HDC\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
histidine decarboxylase (ec 4.1.1.22) (hdc). [source:swissprot;acc:p19113]\vspace{3pt}}&&&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1716\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SH3GL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 2 (sh3 domain protein 2a) (endophilin 1) (een-b1). [source:swissprot;acc:q99962]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.522\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.818\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1717\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OSGEP\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
o-sialoglycoprotein endopeptidase. [source:refseq;acc:nm\_017807]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.058\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.164\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1718\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SH3GL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sh3-containing grb2-like protein 1 (sh3 domain protein 2b) (extra eleven-nineteen leukemia fusion gene) (een) (een fusion partner of mll). [source:swissprot;acc:q99961]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.251\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.553\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01325\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1719\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
helicase (fragment). [source:sptrembl;acc:q92771]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.204\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
189.679\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01322\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
1720\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DDX12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dead/h (asp-glu-ala-asp/his) box polypeptide 11; dead/h box-11 (chl1-related helicase gene-1); yeast chl1 homolog. [source:refseq;acc:nm\_030655]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.205\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1721\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CSNK1D\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
casein kinase i, delta isoform (ec 2.7.1.-) (cki-delta) (ckid). [source:swissprot;acc:p48730]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
227.125\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
224.164\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01321\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1722\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RPS13\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
40s ribosomal protein s13. [source:swissprot;acc:q02546]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.899\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.813\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01319\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1723\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NADK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative inorganic polyphosphate/atp-nad kinase (ec 2.7.1.23) (poly(p)/atp nad kinase). [source:swissprot;acc:o95544]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.147\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01312\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1724\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IPMK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
inositol polyphosphate multikinase. [source:refseq;acc:nm\_152230]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
217.676\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
220.53\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01311\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1725\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AFG3L2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
afg3-like protein 2 (ec 3.4.24.-) (paraplegin-like protein). [source:swissprot;acc:q9y4w6]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1726\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
FUT8\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
alpha-(1,6)-fucosyltransferase (ec 2.4.1.68) (glycoprotein 6-alpha-l- fucosyltransferase) (gdp-fucose--glycoprotein fucosyltransferase) (gdp-l-fuc:n-acetyl-beta-d-glucosaminide alpha1,6-fucosyltransferase) (alpha1-6fuct) (fucosyltransferase 8). [source:swissprot;acc:q9byc5]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1727\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMPA1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase (ec 3.1.3.25) (impase) (imp) (inositol monophosphatase) (lithium-sensitive myo-inositol monophosphatase a1). [source:swissprot;acc:p29218]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.366\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.118\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01308\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1728\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
IMPA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
inositol-1(or 4)-monophosphatase 2 (ec 3.1.3.25) (impase 2) (imp 2) (inositol monophosphatase 2) (myo-inositol monophosphatase a2). [source:swissprot;acc:o14732]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
210.358\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.103\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01305\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1729\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATG12\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
autophagy protein 12-like (apg12-like). [source:swissprot;acc:o94817]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.582\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.028\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01304\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1730\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CABC1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
chaperone-activity of bc1 complex-like, mitochondrial precursor (chaperone-abc1-like). [source:swissprot;acc:q8ni60]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
215.336\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
212.567\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01303\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1731\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADCK2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
aarf domain containing kinase 2; putative ubiquinone biosynthesis protein aarf. [source:refseq;acc:nm\_052853]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1732\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADCK4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
aarf domain containing kinase 4. [source:refseq;acc:nm\_024876]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1733\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADCK1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
aarf domain containing kinase 1. [source:refseq;acc:nm\_020421]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1734\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NOLA2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nucleolar protein family a, member 2; component of the h/aca snornp. [source:refseq;acc:nm\_017838]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.921\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.081\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01296\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1735\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LARS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
leucyl-trna synthetase. [source:refseq;acc:nm\_020117]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.189\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1736\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GTF2F1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
transcription initiation factor iif, alpha subunit (tfiif-alpha) (transcription initiation factor rap74). [source:swissprot;acc:p35269]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.921\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.081\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1737\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LARS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
probable leucyl-trna synthetase, mitochondrial precursor (ec 6.1.1.4) (leucine--trna ligase) (leurs). [source:swissprot;acc:q15031]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.189\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1738\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIPT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lipoate-protein ligase, mitochondrial precursor (ec 6.-.-.-) (lipoate biosynthesis protein) (lipoyl ligase) (lipoyltransferase). [source:swissprot;acc:q9y234]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
206.595\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
209.258\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01289\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1739\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TUBG1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tubulin gamma-1 chain (gamma-1 tubulin) (gamma-tubulin complex component 1) (gcp-1). [source:swissprot;acc:p23258]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1740\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DAD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
defender against cell death 1 (dad-1). [source:swissprot;acc:p46966]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1741\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TCP11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
t-complex 11. [source:refseq;acc:nm\_018679]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1742\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TUBG2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tubulin gamma-2 chain (gamma-2 tubulin). [source:swissprot;acc:q9nrh3]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1743\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
pre-mrna cleavage factor i, 59 kda subunit. [source:refseq;acc:nm\_024811]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.176\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.402\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01288\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1744\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SGPL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sphingosine-1-phosphate lyase 1; sphingosine-1-phosphate lyase. [source:refseq;acc:nm\_003901]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
219.423\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
222.215\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01272\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1745\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4-aminobutyrate aminotransferase, mitochondrial precursor (ec 2.6.1.19) (gamma-amino-n-butyrate transaminase) (gaba transaminase) (gaba aminotransferase) (gaba-at) (gaba-t). [source:swissprot;acc:p80404]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1746\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OAT\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ornithine aminotransferase, mitochondrial precursor (ec 2.6.1.13) (ornithine--oxo-acid aminotransferase). [source:swissprot;acc:p04181]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1747\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ERCC2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tfiih basal transcription factor complex helicase subunit (ec 3.6.1.-) (dna-repair protein complementing xp-d cells) (xeroderma pigmentosum group d complementing protein) (cxpd) (dna excision repair protein ercc-2). [source:swissprot;acc:p18074]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
188.452\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
190.845\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0127\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1748\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
bloom's syndrome protein (ec 3.6.1.-) (recq protein-like 3) (dna helicase, recq-like, type 2). [source:swissprot;acc:p54132]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
215.673\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.971\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01269\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1749\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MLH3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna mismatch repair protein mlh3 (mutl protein homolog 3). [source:swissprot;acc:q9uhc1]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.058\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.485\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01264\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1750\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIMCH1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
similar to lim domain only 7 (fragment). [source:sptrembl;acc:q8n6m2]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.57\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1751\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AP1M2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
adaptor-related protein complex 1, mu 2 subunit (mu-adaptin 2) (adaptor protein complex ap-1 mu-2 subunit) (golgi adaptor ha1/ap1 adaptin mu-2 subunit) (clathrin assembly protein assembly protein complex 1 medium chain 2) (ap-mu chain family member mu1b). [source:swissprot;acc:q9y6q5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.185\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
223.97\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01259\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1752\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BARD1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
brca1-associated ring domain protein 1 (bard-1). [source:swissprot;acc:q99728]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.271\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
218.991\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.01258\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1753\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MSRA\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
peptide methionine sulfoxide reductase (ec 1.8.4.6) (protein- methionine-s-oxide reductase) (peptide met(o) reductase). [source:swissprot;acc:q9uj68]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
220.091\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
217.362\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01256\vspace{3pt}}}\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1754\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PSAT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
phosphoserine aminotransferase (ec 2.6.1.52) (psat). [source:swissprot;acc:q9y617]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1755\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CTPS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ctp synthase (ec 6.3.4.2) (utp--ammonia ligase) (ctp synthetase). [source:swissprot;acc:p17812]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
180.609\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
178.393\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01242\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1756\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEGF6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
megf6 (fragment). [source:sptrembl;acc:o75095]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.811\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
219.09\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1757\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CTPS2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
cytidine triphosphate synthase ii; ctp synthetase type 2; utp-ammonia ligase; ctp synthetase isoform; cytidine 5'-triphosphate synthetase 2. [source:refseq;acc:nm\_019857]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
180.537\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
178.325\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0124\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1758\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PCYT2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ethanolamine-phosphate cytidylyltransferase (ec 2.7.7.14) (phosphorylethanolamine transferase) (ctp:phosphoethanolamine cytidylyltransferase). [source:swissprot;acc:q99447]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
233.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
230.595\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.01238\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1759\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RUVBL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ruvb-like 1 (ec 3.6.1.-) (49-kda tata box-binding protein-interacting protein) (49 kda tbp-interacting protein) (tip49a) (pontin 52) (nuclear matrix protein 238) (nmp 238) (54 kda erythrocyte cytosolic protein) (ecp-54) (tip60-associated protein 54-alpha) (tap54-alpha). [source:swissprot;acc:q9y265]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
219.37\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.086\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
1760\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYL1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin light chain 1, skeletal muscle isoform (mlc1f) (a1 catalytic) (alkali). [source:swissprot;acc:p05976]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
233.45\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
230.595\vspace{3pt}}}&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1761\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MYL3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
myosin light chain 1, slow-twitch muscle b/ventricular isoform (mlc1sb) (alkali). [source:swissprot;acc:p08590]\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
1762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NDUFS6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 13 kda-a subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-13kd-a) (ci-13kd-a). [source:swissprot;acc:o75380]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/